Controlled Substances and Pain Management: Regulatory Oversight, Formularies, and Cost Decisions

Journal of Law, Medicine and Ethics 24 (4):310-316 (1996)
  Copy   BIBTEX

Abstract

Pharmacists, physicians, and other health care personnel practice within an integrated system of laws and regulations that influence many treatment modalities. Capitation, managed care, and other controls strain these relationships by mandating greater oversight of how health care is delivered. From a pharmacists’s perspective, any use of medication requites knowledge of three omnipresent factors: regulatory control, formularies, and economic decision making. My objective is to raise awareness of these issues as they relate to the prescription of pain medication and to pain management generally.All practice-oriented drug law and regulation is based on the federal Controlled Substances Act of 1970. The Act, also known as Title II, is part of a much larger piece of legislation, the Comprehensive Drug Abuse Prevention and Control Act of 1970. CSA was enacted to regulate the manufacturing, distribution, dispensing, and delivery of drugs or substances that are subject to, or have the potential for, abuse or physical or psychological dependence.

Other Versions

No versions found

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2010-08-31

Downloads
106 (#469,948)

6 months
16 (#710,878)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Maximizing the Value of Electronic Prescription Monitoring Programs.David B. Brushwood - 2003 - Journal of Law, Medicine and Ethics 31 (1):41-54.
Challenges in the Federal Regulation of Pain Management Technologies.Lars Noah - 2003 - Journal of Law, Medicine and Ethics 31 (1):55-74.

Add more citations

References found in this work

No references found.

Add more references